HEMATOLOGIC MALIGNANCY
Clinical trials for HEMATOLOGIC MALIGNANCY explained in plain language.
Never miss a new study
Get alerted when new HEMATOLOGIC MALIGNANCY trials appear
Sign up with your email to follow new studies for HEMATOLOGIC MALIGNANCY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for kids after transplant: study tests safer GVHD prevention
Disease control TerminatedThis study looked at a new way to prevent severe graft-versus-host disease (GVHD) in children who had a bone marrow transplant for blood cancers. The goal was to see if stopping certain immune-suppressing drugs early could lower the risk of severe GVHD. Only 3 children took part …
Matched conditions: HEMATOLOGIC MALIGNANCY
Phase: PHASE2 • Sponsor: St. Jude Children's Research Hospital • Aim: Disease control
Last updated Jun 16, 2026 20:17 UTC
-
New antibiotic strategy targets deadly infections in vulnerable patients
Disease control TerminatedThis study tested whether the antibiotic ceftolozane-tazobactam can effectively treat serious Pseudomonas aeruginosa infections in people with blood cancers or those who had a stem cell transplant. Participants received the drug through a vein every 8 hours for 10 to 14 days. Res…
Matched conditions: HEMATOLOGIC MALIGNANCY
Phase: PHASE4 • Sponsor: Weill Medical College of Cornell University • Aim: Disease control
Last updated Jun 15, 2026 19:06 UTC
-
Radiation boost for CAR t fails to launch: pilot study cut short
Disease control TerminatedThis small pilot study tested whether adding radiation therapy could help CAR T cell treatment work better in people with lymphoma that didn't respond to CAR T alone. Only 3 patients were enrolled before the study was stopped early. The main goal was to check safety and side effe…
Matched conditions: HEMATOLOGIC MALIGNANCY
Phase: NA • Sponsor: Massachusetts General Hospital • Aim: Disease control
Last updated Jun 15, 2026 19:06 UTC
-
PET scan may spot silent heart danger in cancer patients on immunotherapy
Diagnosis TerminatedThis pilot study tested whether a special PET scan can find hidden heart inflammation in cancer patients taking immunotherapy drugs. The study enrolled only 2 participants and was terminated early, so results are very limited. The goal was to see if this imaging method could iden…
Matched conditions: HEMATOLOGIC MALIGNANCY
Sponsor: Mayo Clinic • Aim: Diagnosis
Last updated Jun 16, 2026 12:51 UTC